[ad_1] Later 13 years of a success contribution to the corporate, Maria Teresa Pulido will vacate from her function as Well-known Technique Officer on Dec 31 AMSTERDAM, Oct. 31, 2024 /PRNewswire/ — The Board of Administrators […]
Trending Stories
Levine Leichtman Capital Partners Named to Inc.’s 2024 List of Founder-Friendly Investors
[ad_1] LOS ANGELES, Oct. 31, 2024 /PRNewswire/ — Levine Leichtman Capital Partners (“LLCP”) is proud to announce that it has been named to Inc.’s 2024 Founder-Friendly Investors list for the second consecutive year. This prestigious […]
DAISO NEW STORE OPENING IN WHITTIER, CALIFORNIA
[ad_1] WHITTIER, Calif., Oct. 31, 2024 /PRNewswire/ — Daiso, the renowned global retail chain offering a wide range of affordable and unique products, is thrilled to announce the grand opening at The Quad in Whittier, […]
Eisai Completes Rolling Submission to US FDA for LEQEMBI® (lecanemab-irmb) Biologics License Application for Subcutaneous Maintenance Dosing for the Treatment of Early Alzheimer’s Disease Under the Fast Track Status
[ad_1] TOKYO and CAMBRIDGE, Mass., Oct. 31, 2024 /PRNewswire/ — Eisai Co., Ltd. (Headquarters: Tokyo, CEO: Haruo Naito, “Eisai”) and Biogen Inc. (Nasdaq: BIIB, Corporate headquarters: Cambridge, Massachusetts, CEO: Christopher A. Viehbacher, “Biogen”) announced today […]
Eisai completes rolling BLA submission for subcutaneous maintenance dosing of Leqembi® (lecanemab-irmb) in the US
[ad_1] STOCKHOLM, Oct. 31, 2024 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that Eisai has completed the rolling submission of a Biologics License Application (BLA) to the U.S. Food […]
